amlodipine and verapamil

amlodipine has been researched along with verapamil in 127 studies

Research

Studies (127)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (4.72)	18.7374
1990's	33 (25.98)	18.2507
2000's	53 (41.73)	29.6817
2010's	29 (22.83)	24.3611
2020's	6 (4.72)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Bruno-Blanch, L; Gálvez, J; García-Domenech, R	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Ali, N; Palit, P	1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Mason, RP; Moisey, DM; Shajenko, L	1
Simpson, RU; Taylor, JM	1
Goncharevskaya, OA; Johns, EJ; Shakhmatova, EI	1
Gambini, F; Gaviraghi, G; Micheli, D; Quartaroli, M; Tarter, G; Trist, DG	1
Clozel, JP; Hess, P; Véniant, M; Wolfgang, R	1
Block, LH; Emmons, LR; Erne, P; Matthys, H; Perruchoud, A; Roth, M	1
Bühler, FR; Erne, P; Kiowski, W; Linder, L	1
Goldhammer, E; Sharma, SK; Silke, B; Taylor, SH; Verma, SP	1
Bevan, J; Heptinstall, S	1
Lorimer, AR; Smedsrud, T; Tyler, HM; Walker, P	2
Bevan, J; Glusa, E; Heptinstall, S	1
Jackson, N; Sharma, SK; Silke, B; Taylor, SH; Verma, SP	1
Frais, MA; Jackson, N; Midtbo, KA; Reynolds, G; Sharma, S; Silke, B; Taylor, SH; Verma, SP	1
Betteridge, L; Chan, P; Gallagher, K; Munro, E; Patel, M; Schachter, M; Sever, P; Wolfe, J	1
Chauvet-Monges, AM; Crevat, A; Salducci, MD; Tabouy, L	1
Bühler, FR; Clozel, JP; Iberg, N; Schmitt, R	1
Bretnall, AE; Clarke, GS	1
Locher, R; Lupo, E; Vetter, W; Weisser, B	1
August, P; Laragh, JH; Lenz, T	1
Garcha, RS; Hughes, AD; Sever, PS	1
Lasciarrea, A; Manzari, M; Merlo, M; Nazzaro, P; Pirrelli, A; Scarano, AM; Triggiani, R	1
Block, LH; Eickelberg, O; Erne, P; Kohler, E; Roth, M	1
Peterlik, M; Pietschmann, P; Redlich, K; Stulc, T	1
White, CM	1
Orekhov, AN; Pivovarova, EM; Tertov, VV	1
Haraguchi, K; Iga, T; Ito, K; Kotaki, H; Sawada, Y	1
Bacri, AM; Compagnon, P; Iacob, M; Joannides, R; Moore, N; Thuillez, C	1
Backenköhler, U; Dörge, H; Heusch, G; Jalowy, A; Post, H; Schulz, R; Vahlhaus, C	1
Doğrul, A; Yeşilyurt, O	1
Gabbarini, F	1
Mason, PE; Mason, RP; Olmstead, EG; Trumbore, MW; Walter, MF	1
Deedwania, PC; Fakouhi, TD; Frishman, WH; Glasser, S; Johnson, M; Stone, P	1
Hilleman, DE; Mohiuddin, SM; Ryschon, KL; Wurdeman, RL	1
Ford, MD; Kerns, WP; Kline, JA; Tomaszewski, CA; Yuan, TH	1
Mak, IT; Mason, PE; Mason, RP; Trumbore, MW	1
Cascio, WE; Chowdhury, MK; Crouse, JR; Jollis, JG; Massing, MW; Simpson, RJ; Smith, SC	1
Meissner, A; Min, JY; Sandmann, S; Simon, R; Unger, T	1
Göthert, M; Likungu, J; Molderings, GJ	1
Anderson, R; Hollenberg, NK; Williams, GH	1
Frishman, W; Glasser, SP; Johnson, MF; Stone, P; White, WB	1
Avdonin, PV; Buhler, FR; Tkachuk, VA	1
Marche, P; Stepien, O	1
Baican, M; Coltau, M; Domuta, G; Gilau, L; Hecht, A; Pasca, R; Puscas, I	1
Baican, M; Coltau, M; Domuta, G; Gilau, L; Hecht, A; Pasca, R; Puscas, L	1
Matsumori, A; Nunokawa, Y; Sasayama, S	1
Claas, R; Cleutjens, JP; Daemen, MJ; Sandmann, S; Unger, T	1
Eide, I; Lefrandt, JD; Rostrup, M; Sevre, K; Smit, AJ	1
Agabiti-Rosei, E; Castellano, M; de Kam, PJ; Fallon, M; Fluckiger, L; Hausberg, M; Heitmann, J; Lefrandt, JD; Murphy, M; Rahn, KH; Rostrup, M; Sevre, K; Smit, AJ; Urbigkeit, A; van Roon, AM; Zannad, F	1
Agabiti-Rosei, E; Castellano, M; de Kam, PJ; Fallon, M; Hausberg, M; Heitmann, J; Lefrandt, JD; Murphy, M; Rahn, KH; Rostrup, M; Sevre, K; Smit, AJ; Urbigkeit, A; Zannad, F	1
Binggeli, C; Corti, R; Luscher, TF; Noll, G; Sudano, I	1
Ferro, A; Lin, G; Queen, L; Xiao-hong, L; Xu, B	1
Lijnen, PJ	1
Holzhausen, C; Nebe, B; Rychly, J; Urbaszek, W	1
Bernadet-Monrozies, P; Durand, D; Kamar, N; Rostaing, L	1
Allen, TJ; Cao, Z; Cooper, ME; Davis, BJ; de Gasparo, M; Kawachi, H	1
Bidani, AK; Giobbie-Hurder, A; Griffin, KA; Picken, M	1
Berto, IM; Boero, R; Lanfranco, G; Massara, C; Perosa, P; Quarello, F; Rollino, C; Vagelli, G	1
Kirakozov, DA; Lopatin, IuM; Statsenko, ME	1
Afanas'ev, SA; Akhmedov, ShD; Antonchenko, IV; Dzhavadova, GK; Evtushenko, AV; Kandinskiĭ, ML; Kozlov, BN; Popov, SV; Shipulin, VM; Vecherskiĭ, IuIu	1
Ackerley, C; Backx, PH; Dawood, F; Koch, SE; Liu, PP; Oudit, GY; Schwartz, A; Sun, H; Trivieri, MG; Wilson, GJ; Yazdanpanah, M	1
Ghini, B; Lehfeld, LS; Lopes de Faria, JB; Silveira, LA	1
Gatsura, SV	1
Lee, JD; Mitsuke, Y; Nakano, A; Shimizu, H; Ueda, T; Uzui, H; Yue, H	1
Basile, J	1
Faverdin, C; Marche, P; Polidano, E; Yin, X	1
Austin, O; Clunn, GF; Hughes, AD; Lymn, JS; Patel, MK	1
He, L; Ji, BS; Liu, GQ	1
Owecki, M; Sowiński, J	1
Karpov, IuA	1
Blatter, XL; Meier, M; Seelig, A; Seelig, J	1
Abramova, GN; Berenshteĭn, NV; Burmistrova, LF; Iskendeerov, BG; Lokhina, TV; Shibaeva, TM	1
Ozkul, Y	1
Gutkowski, W; Janion, M; Sielski, J; Stepień, A	1
Borowicz, KK; Czuczwar, SJ; Kimber-Trojnar, Z; Luszczki, JJ; Szostakiewicz, B; Trojnar, MK; Trojnar, MP; Zadrozniak, A	1
Bacher, P; Champion, A; Fakouhi, K; Tian, M; Toto, RD	1
Kurola, J; Rapola, J; Sallisalmi, M; Varpula, T	1
Burke, T; Das, R; Plow, EF; Van Wagoner, DR	1
He, L; Ji, BS	1
Bkaily, G; Jacques, D	1
Cao, T; Chen, X; Feng, X; He, H; Liu, D; Luo, Z; Ma, L; Ma, S; Tepel, M; Yan, Z; Yang, D; Zhu, Z	1
Das, R; Plow, EF	1
Matsumori, A; Nishio, R; Nose, Y	1
Gridneva, EV; Iskenderov, BG; Lokhina, TV; Sisina, ON	1
Bălan, H	1
Burmistrova, LF; Iskenderov, BG; Sisina, ON	1
Baron, JA; Bøtker, HE; Jensen, LO; Johansen, MB; Kaltoft, A; Maeng, M; Robertson, DJ; Schmidt, M; Sørensen, HT; Tilsted, HH	1
Cen, J; He, L; Ji, BS; Liu, L	1
Bair, DA; Ita, KB; Kaur, M; Parikh, SJ; Popova, IE	1
Çelik, H; Korkmaz, H; Oğuz, E; Sabuncu, T; Tabur, S	1
Benamer, H; Halna du Fretay, X; Mohammed Saeed, D	1
Barceló, D; Esplugas, S; Gonzalez, O; Pérez, S; Qiang, Z; Sans, C; Xu, K; Zhu, B; Zonja, B	1
Catterall, WA; Gamal El-Din, TM; Pryde, DC; Scheuer, T; Swanson, TM; Tang, L; Zheng, N	1
Kanorskii, SG; Sereda, AF	1
Asadi, S; Nojavan, S; Parsa, M; Tabani, H	1
Bhandari, V; Deep, DK; Dujardin, JC; Salotra, P; Singh, R; Sundar, S; Verma, A	1
Canbolat, S; Nurullahoglu Atalik, KE	1
Belbachir, N; Kitani, T; Lam, CK; Ma, N; Rhee, JW; Shrestha, R; Tian, L; Wnorowski, A; Wu, JC	1
Catterall, WA; Gamal El-Din, TM; Lenaeus, MJ; Tang, L; Zheng, N	1
Bae, SI; Hwang, Y; Kim, HJ; Kim, JY; Lee, SH; Ok, SH; Sohn, JT; Tak, S	1
El Deeb, S; Ratih, R; Stein, M; Wätzig, H	1
Bahteeva, D; Bochkov, P; Cherniaeva, M; Golovina, O; Gorbatenkova, S; Kulikova, M; Mirzaev, K; Ostroumova, O; Rytkin, E; Shevchenko, R; Sychev, D	1
Katsurahara, K; Otsuji, E; Shiozaki, A	1
Arita, T; Fujiwara, H; Ito, H; Katsurahara, K; Komatsu, S; Konishi, H; Kosuga, T; Kubota, T; Kudou, M; Okamoto, K; Otsuji, E; Shimizu, H; Shiozaki, A	1
Abdulaziz, O; Ahmad, S; Ali, N; Ali, W; Aljuaid, A; Allahyani, M; Almehmadi, M; Alsaiari, AA; Ullah, A	1
Ahmad, S; Ali, N; Ali, W; Rahman, SU; Ullah, A	1

Reviews

8 review(s) available for amlodipine and verapamil

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
New drugs for hypertension--variations on old themes. Drug and therapeutics bulletin, 1991, Mar-18, Volume: 29, Issue:6 Topics: Amlodipine; Antihypertensive Agents; Delayed-Action Preparations; Dihydropyridines; Doxazosin; Humans; Hypertension; Isradipine; Nifedipine; Prazosin; Verapamil	1991
Calcium channel blockers in left ventricular dysfunction or congestive heart failure. Connecticut medicine, 1997, Volume: 61, Issue:10 Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Felodipine; Heart Failure; Humans; Nicardipine; Nifedipine; Ventricular Dysfunction, Left; Verapamil	1997
Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation. Journal of human hypertension, 1999, Volume: 13, Issue:7 Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Drug Combinations; Humans; Hypertension; Lisinopril; Treatment Outcome; Verapamil	1999
Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia. Clinical cardiology, 2000, Volume: 23, Issue:7 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Blood Pressure; Calcium Channel Blockers; Chronotherapy; Delayed-Action Preparations; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Retrospective Studies; Verapamil	2000
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Presse medicale (Paris, France : 1983), 2002, Nov-09, Volume: 31, Issue:36 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Endothelins; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Verapamil	2002
The role of existing and newer calcium channel blockers in the treatment of hypertension. Journal of clinical hypertension (Greenwich, Conn.), 2004, Volume: 6, Issue:11 Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension; Nifedipine; Nitrendipine; Treatment Outcome; Verapamil	2004
[Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy]. Kardiologiia, 2005, Volume: 45, Issue:12 Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Enalapril; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Perindopril; Placebos; Risk Factors; Surveys and Questionnaires; Time Factors; Vasodilator Agents; Verapamil	2005

Trials

20 trial(s) available for amlodipine and verapamil

Article	Year
Arterial vasodilator effects of the dihydropyridine calcium antagonist amlodipine alone and in combination with verapamil in systemic hypertension. The American journal of cardiology, 1990, Dec-15, Volume: 66, Issue:20 Topics: Amlodipine; Calcium Channel Blockers; Drug Therapy, Combination; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nitroprusside; Regional Blood Flow; Vasodilator Agents; Verapamil	1990
An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease. Cardiovascular drugs and therapy, 1990, Volume: 4, Issue:2 Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cardiac Output; Coronary Disease; Diltiazem; Exercise; Hemodynamics; Humans; Middle Aged; Nifedipine; Prospective Studies; Rest; Verapamil	1990
Comparison of amlodipine and verapamil in the treatment of mild to moderate hypertension. Journal of cardiovascular pharmacology, 1988, Volume: 12 Suppl 7 Topics: Adolescent; Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Pulse; Random Allocation; Verapamil	1988
A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group. Journal of human hypertension, 1989, Volume: 3, Issue:3 Topics: Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Placebos; Pulse; Random Allocation; Verapamil	1989
Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery disease. Clinical pharmacology and therapeutics, 1987, Volume: 42, Issue:4 Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Diltiazem; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Male; Middle Aged; Nicardipine; Nifedipine; Nisoldipine; Prospective Studies; Random Allocation; Verapamil	1987
Antihypertensive treatment with verapamil and amlodipine. Their effect on the functional autonomic and cardiovascular stress responses. European heart journal, 1995, Volume: 16, Issue:9 Topics: Adult; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Stress, Physiological; Stress, Psychological; Treatment Outcome; Verapamil	1995
Divergent effects of verapamil and amlodipine at rest and during exercise. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1998, Volume: 16, Issue:1 Topics: Adult; Amlodipine; Calcium Channel Blockers; Double-Blind Method; Epinephrine; Hemodynamics; Humans; Male; Norepinephrine; Physical Exertion; Rest; Verapamil	1998
Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. The American journal of cardiology, 1999, Feb-15, Volume: 83, Issue:4 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Middle Aged; Treatment Outcome; Verapamil	1999
Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension. Archives of internal medicine, 2000, May-22, Volume: 160, Issue:10 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Quality of Life; Treatment Outcome; Verapamil	2000
Hypotensive effect of calcium channel blockers is parallel with carbonic anhydrase I inhibition. Clinical pharmacology and therapeutics, 2000, Volume: 68, Issue:4 Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Carbonic Anhydrases; Erythrocytes; Female; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Rabbits; Verapamil	2000
Less adrenergic response to mental task during verapamil compared to amlodipine treatment in hypertensive subjects. Blood pressure, 2001, Volume: 10, Issue:2 Topics: Adrenergic Agents; Adult; Aged; Amlodipine; Antihypertensive Agents; Baroreflex; Blood Pressure; Calcium Channel Blockers; Catecholamines; Female; Heart Rate; Humans; Hypertension; Intelligence Tests; Male; Middle Aged; Norepinephrine; Stress, Psychological; Verapamil	2001
The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study. American journal of hypertension, 2001, Volume: 14, Issue:11 Pt 1 Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Autonomic Nervous System; Baroreflex; Blood Pressure; Calcium Channel Blockers; Carrier Proteins; Cross-Over Studies; Dihydropyridines; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Steroid Isomerases; Treatment Outcome; Verapamil	2001
Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension. British journal of clinical pharmacology, 2001, Volume: 52, Issue:6 Topics: Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Sphygmomanometers; Verapamil	2001
Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:4 Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Double-Blind Method; Epinephrine; Female; Heart Rate; Humans; Hypertension; Male; Muscles; Nifedipine; Norepinephrine; Sympathetic Nervous System; Verapamil	2002
The verapamil versus amlodipine in nondiabetic nephropathies treated with trandolapril (VVANNTT) study. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 42, Issue:1 Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Hemodynamics; Humans; Indoles; Male; Middle Aged; Prospective Studies; Proteinuria; Safety; Treatment Outcome; Verapamil	2003
[Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension]. Klinicheskaia meditsina, 2006, Volume: 84, Issue:11 Topics: Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Drug Therapy, Combination; Echocardiography, Doppler; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Treatment Outcome; Verapamil	2006
Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy. Journal of clinical hypertension (Greenwich, Conn.), 2008, Volume: 10, Issue:10 Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Synergism; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Prospective Studies; Proteinuria; Treatment Outcome; Verapamil	2008
[Comparative efficiency of indapamide combinations with various derivaties of calcium antagonists in patients with arterial hypertension]. Klinicheskaia meditsina, 2010, Volume: 88, Issue:1 Topics: Adult; Aged; Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography, Doppler; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Middle Aged; Treatment Outcome; Ventricular Function, Left; Verapamil	2010
Bedtime versus at awakening administration of BP lowering drugs--is it the way to success? Romanian journal of internal medicine = Revue roumaine de medecine interne, 2009, Volume: 47, Issue:4 Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Cohort Studies; Drug Chronotherapy; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Treatment Outcome; Verapamil	2009
The effects of calcium channel blockers on nephropathy and pigment epithelium-derived factor in the treatment of hypertensive patients with type 2 diabetes mellitus. Clinical and experimental hypertension (New York, N.Y. : 1993), 2015, Volume: 37, Issue:3 Topics: Aged; Albuminuria; Amlodipine; Blood Pressure; Calcium Channel Blockers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Monitoring; Eye Proteins; Female; Glycated Hemoglobin; Humans; Hypertension; Kidney Function Tests; Male; Middle Aged; Nerve Growth Factors; Renal Elimination; Serpins; Treatment Outcome; Verapamil	2015

Other Studies

99 other study(ies) available for amlodipine and verapamil

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship	2003
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Oral Therapy with Amlodipine and Lacidipine, 1,4-Dihydropyridine Derivatives Showing Activity against Experimental Visceral Leishmaniasis. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1 Topics: Administration, Oral; Amlodipine; Animals; Antiprotozoal Agents; Dihydropyridines; Leishmania donovani; Leishmaniasis, Visceral; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Treatment Outcome	2008
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data. European journal of medicinal chemistry, 2009, Volume: 44, Issue:11 Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Glutathione; Pharmacology; Sulfur Radioisotopes	2011
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer. Molecular pharmacology, 1992, Volume: 41, Issue:2 Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cell Membrane; Cholesterol; Dihydropyridines; Diltiazem; Electrons; Isradipine; Lipid Bilayers; Myocardium; Nifedipine; Nimodipine; Nitrendipine; Phosphatidylcholines; Rabbits; Verapamil	1992
Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse. Cancer research, 1992, May-01, Volume: 52, Issue:9 Topics: Amlodipine; Animals; Breast Neoplasms; Calcium; Calcium Channel Blockers; Cell Division; Culture Media; Diltiazem; DNA, Neoplasm; Drug Screening Assays, Antitumor; Mice; Mice, Nude; Nifedipine; Tumor Cells, Cultured; Verapamil	1992
The influence of amlodipine and verapamil on ion and water transport in the nephron, skin and urinary bladder of amphibians. Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology, 1991, Volume: 98, Issue:2-3 Topics: Amlodipine; Animals; Capillaries; Kidney; Kidney Tubules; Male; Nephrons; Nifedipine; Perfusion; Rana temporaria; Salamandridae; Skin; Sodium; Urinary Bladder; Vasopressins; Verapamil; Water	1991
The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem. Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:3 Topics: Amlodipine; Anesthesia; Animals; Blood Gas Analysis; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Diltiazem; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Hemodynamics; Male; Myocardial Contraction; Nifedipine; Nitrendipine; Stroke Volume; Vascular Resistance; Verapamil	1991
Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine. Journal of cardiovascular pharmacology, 1991, Volume: 18 Suppl 10 Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Hemodynamics; Male; Mibefradil; Nifedipine; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes; Verapamil	1991
Ca(2+)-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor. Proceedings of the National Academy of Sciences of the United States of America, 1991, Oct-15, Volume: 88, Issue:20 Topics: Amlodipine; Calcium Channel Blockers; Cell Division; Cell Line; Cell Membrane; DNA Replication; Fibroblasts; Gene Expression; Genes; Humans; Hydroxymethylglutaryl CoA Reductases; Kinetics; Nifedipine; Nitrendipine; Platelet-Derived Growth Factor; Receptors, LDL; RNA, Messenger; Skin; Transcription, Genetic; Verapamil	1991
How can we inhibit 5-HT-induced platelet aggregation and why should we bother? Folia haematologica (Leipzig, Germany : 1928), 1988, Volume: 115, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Amlodipine; Female; Humans; Male; Middle Aged; Nifedipine; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Serotonin Antagonists; Verapamil	1988
Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation. Thrombosis research, 1989, Jul-15, Volume: 55, Issue:2 Topics: Adenosine Diphosphate; Amlodipine; Calcium Channel Blockers; Collagen; Diltiazem; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin Antagonists; Verapamil	1989
A hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease. American heart journal, 1989, Volume: 118, Issue:5 Pt 2 Topics: Amlodipine; Calcium Channel Blockers; Coronary Disease; Diltiazem; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Physical Exertion; Rest; Verapamil	1989
Effect of calcium channel blockers on the growth of human vascular smooth muscle cells derived from saphenous vein and vascular graft stenoses. Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:5 Topics: Amlodipine; Cell Division; Cells, Cultured; Diltiazem; DNA; Graft Occlusion, Vascular; Humans; L-Lactate Dehydrogenase; Muscle, Smooth, Vascular; Saphenous Vein; Verapamil	1994
Protective effect of some calcium antagonists against mitochondrial calcium injury. International journal of tissue reactions, 1994, Volume: 16, Issue:5-6 Topics: Adenosine Triphosphate; Amlodipine; Animals; Antihypertensive Agents; Bepridil; Calcium Channel Blockers; Diltiazem; In Vitro Techniques; Male; Mitochondria, Liver; Myocardial Ischemia; Nicardipine; Rats; Rats, Wistar; Verapamil	1994
Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arteriosclerosis, thrombosis, and vascular biology, 1995, Volume: 15, Issue:8 Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Carotid Artery Injuries; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Membrane Potentials; Mibefradil; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Tetrahydronaphthalenes; Tunica Intima; Verapamil	1995
Investigation and optimisation of the use of micellar electrokinetic chromatography for the analysis of six cardiovascular drugs. Journal of chromatography. A, 1995, May-12, Volume: 700, Issue:1-2 Topics: Amlodipine; Atenolol; Cardiovascular Agents; Chromatography; Diltiazem; Electrochemistry; Hydrogen-Ion Concentration; Kinetics; Micelles; Nicardipine; Nifedipine; Osmosis; Sodium Dodecyl Sulfate; Verapamil	1995
In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol. Biochemical and biophysical research communications, 1994, Sep-30, Volume: 203, Issue:3 Topics: Adult; Amlodipine; Antioxidants; Calcium Channel Blockers; Copper; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Humans; Isradipine; Lipoproteins, LDL; Oxidation-Reduction; Reference Values; Thiobarbituric Acid Reactive Substances; Verapamil; Vitamin E	1994
Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure. American journal of hypertension, 1993, Volume: 6, Issue:4 Topics: Amlodipine; Antihypertensive Agents; Dipeptides; Hemodynamics; Humans; Kidney Failure, Chronic; Lisinopril; Middle Aged; Potassium; Proteinuria; Renal Circulation; Renin; Verapamil	1993
The action of amlodipine on human subcutaneous resistance arteries studied in vitro. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:2 Topics: Amlodipine; Arteries; Humans; In Vitro Techniques; Membrane Potentials; Vascular Resistance; Verapamil	1993
Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proceedings of the National Academy of Sciences of the United States of America, 1996, May-28, Volume: 93, Issue:11 Topics: Amlodipine; Becaplermin; Calcium Channel Blockers; Cells, Cultured; Collagen; Collagenases; Dihydropyridines; Diltiazem; Enzyme Activation; Extracellular Matrix; Felodipine; Fibroblasts; Humans; Kinetics; Lung; Metalloendopeptidases; Muscle, Smooth, Vascular; Nitrobenzenes; Piperazines; Platelet-Derived Growth Factor; Procollagen; Proline; Proto-Oncogene Proteins c-sis; Transcription, Genetic; Verapamil	1996
Comparative study on the effect of calcium channel blockers on basal and parathyroid hormone-induced bone resorption in vitro. Pharmacology & toxicology, 1997, Volume: 80, Issue:6 Topics: Amlodipine; Animals; Bone Resorption; Calcium Channel Blockers; Gallopamil; Mice; Nifedipine; Organ Culture Techniques; Parathyroid Hormone; Parietal Bone; Specific Pathogen-Free Organisms; Verapamil	1997
The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells. Cardiology, 1998, Volume: 89, Issue:2 Topics: Adult; Amlodipine; Antihypertensive Agents; Aorta; Arteriosclerosis; Cell Division; Cells, Cultured; Cholesterol; DNA; Humans; Indoles; Male; Middle Aged; Muscle, Smooth, Vascular; Propranolol; Protein Biosynthesis; Tunica Intima; Verapamil	1998
Catalepsy induced by calcium channel blockers in mice. Biopharmaceutics & drug disposition, 1998, Volume: 19, Issue:2 Topics: Amlodipine; Animals; Binding, Competitive; Calcium Channel Blockers; Catalepsy; Dihydropyridines; Diltiazem; Disease Models, Animal; Flunarizine; Male; Mice; Muscarinic Antagonists; Nitrobenzenes; Piperazines; Predictive Value of Tests; Receptors, Cholinergic; Receptors, Dopamine D1; Receptors, Dopamine D2; Scopolamine; Time Factors; Verapamil	1998
Unique cardioprotective action of the new calcium antagonist mibefradil. Circulation, 1999, Jan-19, Volume: 99, Issue:2 Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Glyburide; Heart; Heart Rate; Heart Ventricles; Mibefradil; Myocardial Infarction; Pressure; Swine; Tetrahydronaphthalenes; Verapamil	1999
Effects of Ca2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice. European journal of pharmacology, 1999, Jan-08, Volume: 364, Issue:2-3 Topics: Amlodipine; Animals; Apomorphine; Benzazepines; Bromocriptine; Calcium Channel Blockers; Diltiazem; Dopamine Antagonists; Female; Haloperidol; Heterocyclic Compounds, 4 or More Rings; Mice; Morphine; Motor Activity; Nicardipine; Time Factors; Verapamil	1999
A 61-year-old man with Holmes' heart. Lancet (London, England), 1999, Feb-20, Volume: 353, Issue:9153 Topics: Amlodipine; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiac Output, Low; Heart Defects, Congenital; Heart Ventricles; Humans; Male; Middle Aged; Shock, Cardiogenic; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Treatment Outcome; Verapamil	1999
Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. Journal of molecular and cellular cardiology, 1999, Volume: 31, Issue:1 Topics: Amlodipine; Antihypertensive Agents; Antioxidants; Calcium; Calorimetry, Differential Scanning; Diltiazem; Dimyristoylphosphatidylcholine; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Inhibitory Concentration 50; Lipid Peroxidation; Phosphatidylcholines; Verapamil	1999
Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. Journal of toxicology. Clinical toxicology, 1999, Volume: 37, Issue:4 Topics: Adolescent; Adult; Amlodipine; Atenolol; Calcium Channel Blockers; Chemotherapy, Adjuvant; Female; Glucose; Hemodynamics; Humans; Insulin; Male; Middle Aged; Suicide, Attempted; Verapamil	1999
Antioxidant properties of calcium antagonists related to membrane biophysical interactions. The American journal of cardiology, 1999, Aug-19, Volume: 84, Issue:4A Topics: Amlodipine; Animals; Antioxidants; Calcium Channel Blockers; Calorimetry, Differential Scanning; Diltiazem; Dose-Response Relationship, Drug; Intracellular Membranes; Lipid Peroxidation; Male; Microsomes, Liver; Radioligand Assay; Rats; Rats, Sprague-Dawley; Verapamil; X-Ray Diffraction	1999
Calcium channel blockers and mortality in elderly patients with myocardial infarction. Archives of internal medicine, 1999, Oct-25, Volume: 159, Issue:19 Topics: Aged; Aged, 80 and over; Amlodipine; Bepridil; Calcium Channel Blockers; Diltiazem; Female; Humans; Logistic Models; Male; Myocardial Infarction; Nifedipine; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; United States; Verapamil	1999
Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:3 Topics: Adrenergic beta-Agonists; Aequorin; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Heart; Heart Function Tests; Hemodynamics; Isometric Contraction; Isoproterenol; Male; Mibefradil; Myocardial Contraction; Myocardial Infarction; Myocardium; Papillary Muscles; Rats; Rats, Wistar; Verapamil	1999
N-Type calcium channels control sympathetic neurotransmission in human heart atrium. Circulation, 2000, Feb-01, Volume: 101, Issue:4 Topics: Adult; Aged; Amlodipine; Calcium Channel Blockers; Calcium Channels, N-Type; Diltiazem; Electric Stimulation; Female; Heart; Heart Atria; Humans; Male; Mibefradil; Middle Aged; Norepinephrine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Sympathetic Nervous System; Synaptic Transmission; Verapamil	2000
Ca2+-agonistic effect of a T-type Ca-channel blocker mibefradil (Ro 40-5967). Membrane & cell biology, 2000, Volume: 13, Issue:5 Topics: Amlodipine; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Cells, Cultured; Coronary Vessels; Diltiazem; Mibefradil; Muscle, Smooth, Vascular; Swine; Verapamil	2000
Amlodipine inhibits thapsigargin-sensitive CA(2+) stores in thrombin-stimulated vascular smooth muscle cells. American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:3 Topics: Amlodipine; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Transporting ATPases; Cells, Cultured; Diltiazem; Dose-Response Relationship, Drug; Enzyme Inhibitors; Intracellular Fluid; Isradipine; Muscle, Smooth, Vascular; Potassium Chloride; Rats; Rats, Inbred WKY; Sarcoplasmic Reticulum; Signal Transduction; Thapsigargin; Thrombin; Verapamil	2000
Calcium channel blockers reduce blood pressure in part by inhibiting vascular smooth muscle carbonic anhydrase I. Cardiovascular drugs and therapy, 2000, Volume: 14, Issue:5 Topics: Aged; Amlodipine; Analysis of Variance; Animals; Blood Pressure; Calcium Channel Blockers; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Drug Administration Schedule; Erythrocytes; Humans; Isoenzymes; Middle Aged; Muscle, Smooth, Vascular; Rabbits; Verapamil	2000
Nifedipine inhibits activation of transcription factor NF-kappaB. Life sciences, 2000, Oct-13, Volume: 67, Issue:21 Topics: Amlodipine; Calcium Channel Blockers; Cell Migration Inhibition; Diltiazem; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Interleukin-1; Lipopolysaccharides; Luciferases; Lung Neoplasms; Lymphocyte Activation; Macrophages; NF-kappa B; Nifedipine; Tetradecanoylphorbol Acetate; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Verapamil	2000
Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats. Journal of cardiovascular pharmacology, 2001, Volume: 37, Issue:1 Topics: Amlodipine; Animals; Calcium Channel Blockers; Heart Failure; Hemodynamics; Hypertrophy, Left Ventricular; Male; Mibefradil; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Ventricular Remodeling; Verapamil	2001
Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism. British journal of pharmacology, 2002, Volume: 136, Issue:3 Topics: Amlodipine; Animals; Calcium Channel Blockers; Cells, Cultured; Endothelium, Vascular; Femoral Artery; Humans; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Rabbits; Receptor, Bradykinin B2; Receptors, Bradykinin; Vasodilation; Verapamil	2002
Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil. Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:3 Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Adhesion; Humans; Leukocytes; Mibefradil; Verapamil	2002
Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil. Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:3 Topics: Adult; Amlodipine; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; CD18 Antigens; Cell Adhesion; Cells, Cultured; Cytoskeleton; Female; Flow Cytometry; Granulocytes; Humans; L-Selectin; Leukocytes; Male; Mibefradil; Microscopy, Confocal; Verapamil	2002
Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin. Journal of hypertension, 2003, Volume: 21, Issue:1 Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Hypertension; Kidney Glomerulus; Male; Membrane Proteins; Proteins; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Sclerosis; Systole; Tetrazoles; Valine; Valsartan; Verapamil	2003
Low protein diet mediated renoprotection in remnant kidneys: Renal autoregulatory versus hypertrophic mechanisms. Kidney international, 2003, Volume: 63, Issue:2 Topics: Amlodipine; Animals; Blood Pressure; Calcium Channel Blockers; Cytoprotection; Diet, Protein-Restricted; Homeostasis; Hypertrophy; Kidney; Male; Nephrectomy; Rats; Rats, Sprague-Dawley; Telemetry; Time Factors; Verapamil	2003
Parkinsonian syndrome and calcium channel blockers. Prescrire international, 2003, Volume: 12, Issue:64 Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Humans; Parkinsonian Disorders; Verapamil	2003
[Heart rate variability in patients with hypertension and type 2 diabetes treated with long acting calcium antagonists]. Kardiologiia, 2003, Volume: 43, Issue:5 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Verapamil	2003
[Effect of calcium antagonists verapamil and amlodipine on the risk of development of atrial fibrillation after coronary artery bypass grafting]. Kardiologiia, 2003, Volume: 43, Issue:7 Topics: Adult; Aged; Amlodipine; Atrial Fibrillation; Calcium Channel Blockers; Coronary Artery Bypass; Humans; Male; Middle Aged; Myocardial Ischemia; Postoperative Complications; Verapamil	2003
L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nature medicine, 2003, Volume: 9, Issue:9 Topics: Amlodipine; Animals; Biological Transport; Calcium Channel Blockers; Calcium Channels; Cardiomyopathies; Iron; Iron Overload; Male; Mice; Mice, Inbred Strains; Myocardium; Myocytes, Cardiac; Oxidative Stress; Survival Rate; Verapamil	2003
Early blood pressure normalization independent of the class of antihypertensive agent prevents augmented renal fibronectin and albuminuria in experimental diabetic nephropathy. Kidney & blood pressure research, 2004, Volume: 27, Issue:2 Topics: Albuminuria; Amlodipine; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Synergism; Fibronectins; Glomerular Filtration Rate; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Verapamil	2004
Oxygen-dependent mechanisms underlying the antiischemic effect of verapamil and amlodipine. Bulletin of experimental biology and medicine, 2004, Volume: 137, Issue:1 Topics: Amlodipine; Animals; Hemoglobins; Lipid Peroxidation; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Oxygen; Rats; Superoxide Dismutase; Verapamil	2004
Different effects of calcium channel blockers on matrix metalloproteinase-2 expression in cultured rat cardiac fibroblasts. Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2 Topics: Amlodipine; Animals; Animals, Newborn; Benzoquinones; Calcium; Calcium Channel Blockers; Cells, Cultured; Diltiazem; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibroblasts; Genistein; Lactams, Macrocyclic; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocardium; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Nitroprusside; Protein Kinase Inhibitors; Quinones; Rats; Rats, Wistar; Rifabutin; Verapamil	2004
Role of L-type calcium channel blocking in epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2. Journal of hypertension, 2005, Volume: 23, Issue:2 Topics: Amlodipine; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; ErbB Receptors; Isradipine; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Thrombin; Verapamil	2005
Adult hypertension: reducing cardiovascular morbidity and mortality. Prescrire international, 2005, Volume: 14, Issue:75 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Alcohol Drinking; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Determination; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Diltiazem; Diuretics; Drug Evaluation; Health Behavior; Humans; Hypertension; Losartan; Obesity; Renal Insufficiency; Sodium; Stroke; Verapamil	2005
Effect of serum withdrawal on the contribution of L-type calcium channels (CaV1.2) to intracellular Ca2+ responses and chemotaxis in cultured human vascular smooth muscle cells. British journal of pharmacology, 2005, Volume: 145, Issue:6 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Actins; Amlodipine; Becaplermin; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Chemotaxis; Culture Media, Serum-Free; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Saphenous Vein; Verapamil	2005
Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Life sciences, 2005, Sep-16, Volume: 77, Issue:18 Topics: Amlodipine; Analysis of Variance; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Therapy; Flow Cytometry; Fluorescence; Humans; K562 Cells; Neoplasms; Rhodamine 123; Tetrazolium Salts; Thiazoles; Time Factors; Verapamil	2005
[Successful pharmacological treatment of hyperinsulinemic hypoglycemia with verapamil and amlodipine--case report]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2005, Volume: 19, Issue:110 Topics: Aged, 80 and over; Amlodipine; Calcium Channel Blockers; Female; Humans; Hyperinsulinism; Hypertension; Hypoglycemia; Insulinoma; Pancreatic Neoplasms; Treatment Outcome; Verapamil	2005
Interaction of verapamil with lipid membranes and P-glycoprotein: connecting thermodynamics and membrane structure with functional activity. Biophysical journal, 2006, Oct-15, Volume: 91, Issue:8 Topics: Amlodipine; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Fatty Acids; Lipid Bilayers; Mice; NIH 3T3 Cells; Nimodipine; Nuclear Magnetic Resonance, Biomolecular; Thermodynamics; Verapamil	2006
Ivabradine: new drug. Best avoided in stable angina. Prescrire international, 2007, Volume: 16, Issue:88 Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Benzazepines; Calcium Channel Blockers; Cost-Benefit Analysis; Drug Approval; Europe; Humans; Randomized Controlled Trials as Topic; Verapamil	2007
Influence of calcium channel blocker drugs in neuromuscular transmission. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2007, Volume: 118, Issue:9 Topics: Adult; Amlodipine; Calcium Channel Blockers; Electromyography; Female; Fingers; Humans; Hypertension; Male; Middle Aged; Muscle Contraction; Muscle, Skeletal; Neuromuscular Junction; Synaptic Transmission; Verapamil	2007
Is the intra-aortic balloon pump a method of brain protection during cardiogenic shock after drug intoxication? The Journal of emergency medicine, 2010, Volume: 38, Issue:2 Topics: Adolescent; Adrenergic beta-Antagonists; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Brain Diseases; Calcium Channel Blockers; Female; Humans; Ibuprofen; Intra-Aortic Balloon Pumping; Metoprolol; Shock, Cardiogenic; Suicide, Attempted; Verapamil	2010
Effects of amlodipine, diltiazem, and verapamil on the anticonvulsant action of topiramate against maximal electroshock-induced seizures in mice. Canadian journal of physiology and pharmacology, 2008, Volume: 86, Issue:3 Topics: Amlodipine; Animals; Anticonvulsants; Behavior, Animal; Brain; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Electroshock; Fluorescence Polarization Immunoassay; Fructose; Mice; Motor Skills; Seizures; Topiramate; Verapamil	2008
Treatment of serious calcium channel blocker overdose with levosimendan, a calcium sensitizer. Anesthesia and analgesia, 2009, Volume: 108, Issue:3 Topics: Acidosis, Lactic; Amlodipine; Calcium Channel Blockers; Cardiotonic Agents; Coma; Drug Overdose; Echocardiography; Epinephrine; Female; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Shock; Simendan; Vasoconstrictor Agents; Verapamil	2009
L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages. Circulation research, 2009, Jul-17, Volume: 105, Issue:2 Topics: Amlodipine; Animals; Anti-Inflammatory Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cell Differentiation; Cell Movement; Cells, Cultured; Down-Regulation; Female; Humans; Macrophages; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasminogen; Receptors, Cell Surface; RNA Interference; Time Factors; Verapamil	2009
CJX1, an amlodipine derivative, interacts with ATPase of human P-glycoprotein. Cell biology international, 2009, Volume: 33, Issue:10 Topics: Adenosine Triphosphatases; Amlodipine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Calcium Channel Blockers; Cell Line, Tumor; Cyclosporine; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Verapamil	2009
L-type calcium channel antagonists and suppression of expression of plasminogen receptors: is the missing link the L-type calcium channel? Circulation research, 2009, Jul-17, Volume: 105, Issue:2 Topics: Amlodipine; Animals; Anti-Inflammatory Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cell Differentiation; Cell Movement; Down-Regulation; Humans; Macrophages; Membrane Potentials; Plasminogen; Receptors, Cell Surface; Verapamil	2009
Increased rhythmicity in hypertensive arterial smooth muscle is linked to transient receptor potential canonical channels. Journal of cellular and molecular medicine, 2010, Volume: 14, Issue:10 Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Boron Compounds; Calcium; Calcium Channels; Hypertension; Imidazoles; In Vitro Techniques; Muscle, Smooth, Vascular; Norepinephrine; Periodicity; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan; Tetrazoles; TRPC Cation Channels; Verapamil	2010
A new function for old drugs. Cell cycle (Georgetown, Tex.), 2010, Feb-15, Volume: 9, Issue:4 Topics: Amlodipine; Animals; Anti-Inflammatory Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Macrophages; Mice; Plasminogen; Receptors, Peptide; Verapamil	2010
Calcium channel blockers differentially modulate cytokine production by peripheral blood mononuclear cells. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:3 Topics: Amlodipine; Calcium Channel Blockers; Cytokines; Diltiazem; Humans; In Vitro Techniques; Interferon-gamma; Interleukin-1alpha; Interleukin-1beta; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Nifedipine; Tumor Necrosis Factor-alpha; Verapamil	2010
[Selection of rational combinations of indapamide with various of calcium antagonists in patients with arterial hypertension]. Kardiologiia, 2011, Volume: 51, Issue:4 Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart Failure, Diastolic; Humans; Hypertension; Indapamide; Male; Middle Aged; Treatment Outcome; Ventricular Dysfunction, Left; Verapamil	2011
Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events. European journal of clinical investigation, 2012, Volume: 42, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Cardiovascular Diseases; Child; Child, Preschool; Clopidogrel; Cohort Studies; Denmark; Drug Interactions; Felodipine; Female; Humans; Infant; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Stents; Ticlopidine; Verapamil; Young Adult	2012
Interaction of CJY, an isoflavone, with ATPase of P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Drug research, 2013, Volume: 63, Issue:8 Topics: Adenosine Triphosphatases; Amlodipine; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Neoplasm; Humans; Isoflavones; K562 Cells; Rhodamine 123; Verapamil	2013
Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2014, Volume: 86, Issue:2 Topics: Administration, Cutaneous; Amlodipine; Animals; Drug Delivery Systems; Microinjections; Needles; Skin; Skin Absorption; Swine; Verapamil	2014
[Diagnosis and treatment of spastic angina revealed by cardiac arrest]. Annales de cardiologie et d'angeiologie, 2014, Volume: 63, Issue:6 Topics: Adult; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Defibrillators, Implantable; Electrocardiography; Heart Arrest; Humans; Male; Verapamil	2014
Degradation kinetics and pathways of three calcium channel blockers under UV irradiation. Water research, 2015, Dec-01, Volume: 86 Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Disinfection; Kinetics; Photolysis; Ultraviolet Rays; Verapamil; Wastewater; Water Pollutants, Chemical	2015
Structural basis for inhibition of a voltage-gated Ca Nature, 2016, 09-01, Volume: 537, Issue:7618 Topics: Allosteric Regulation; Amines; Amlodipine; Animals; Bacterial Proteins; Binding Sites; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line; Crystallography, X-Ray; Dihydropyridines; Lipids; Models, Molecular; Moths; Mutation; Niacin; Protein Subunits; Verapamil	2016
[Comparison of Verapamil and Amlodipine for Treatment of Chronic Heart Failure With Preserved Left Ventricular Ejection Fraction in Patients With Hypertensive Disease]. Kardiologiia, 2016, Volume: 56, Issue:12 Topics: Aged; Amlodipine; Antihypertensive Agents; Echocardiography; Exercise Tolerance; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Ventricular Function, Left; Verapamil	2016
Introduction of agarose gel as a green membrane in electromembrane extraction: An efficient procedure for the extraction of basic drugs with a wide range of polarities. Journal of chromatography. A, 2017, May-12, Volume: 1497 Topics: Amlodipine; Electricity; Green Chemistry Technology; Hydrogen-Ion Concentration; Limit of Detection; Membranes, Artificial; Morphine; Rivastigmine; Sepharose; Verapamil; Wastewater	2017
Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani. International journal for parasitology. Drugs and drug resistance, 2017, Volume: 7, Issue:3 Topics: Amlodipine; Animals; Anti-Bacterial Agents; Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Drug Resistance; Gene Expression Profiling; Humans; Leishmania donovani; Leishmaniasis, Visceral; Life Cycle Stages; Macrophages; Metabolic Networks and Pathways; Mice; Nitric Oxide; Parasitic Sensitivity Tests; Paromomycin; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Verapamil	2017
Moderate hypothermia and responses to calcium channel blockers - Role of the nitric oxide. Physiology international, 2018, Mar-01, Volume: 105, Issue:1 Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cold Temperature; Coronary Vessels; Dihydropyridines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypothermia, Induced; In Vitro Techniques; Nitric Oxide; Nitric Oxide Synthase Type III; Vasodilation; Vasodilator Agents; Verapamil	2018
Identifying the Transcriptome Signatures of Calcium Channel Blockers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Circulation research, 2019, 07-05, Volume: 125, Issue:2 Topics: Amlodipine; Calcium Channel Blockers; Cell Differentiation; Cells, Cultured; Diltiazem; Humans; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Myosin Heavy Chains; Nifedipine; Transcriptome; Verapamil	2019
Structural Basis for Diltiazem Block of a Voltage-Gated Ca Molecular pharmacology, 2019, Volume: 96, Issue:4 Topics: Allosteric Regulation; Amlodipine; Animals; Binding Sites; Calcium Channel Blockers; Calcium Channels; Crystallography, X-Ray; Diltiazem; Humans; Models, Molecular; Protein Conformation; Verapamil	2019
Lipid emulsion inhibits the vasodilation induced by a toxic dose of amlodipine in isolated rat aortae. International journal of medical sciences, 2019, Volume: 16, Issue:12 Topics: Amlodipine; Animals; Aorta; Calcium Channels, L-Type; Emulsions; Humans; Lipids; Male; Organ Culture Techniques; Rats; rho-Associated Kinases; Signal Transduction; Vasodilation; Verapamil	2019
Investigation of the enantioselective interaction between selected drug enantiomers and human serum albumin by mobility shift-affinity capillary electrophoresis. Journal of separation science, 2020, Volume: 43, Issue:20 Topics: Amlodipine; Electrophoresis, Capillary; Humans; Molecular Structure; Serum Albumin, Human; Stereoisomerism; Verapamil	2020
Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation. Drug metabolism and personalized therapy, 2020, 09-04, Volume: 35, Issue:3 Topics: Aged, 80 and over; Amlodipine; Atrial Fibrillation; Calcium Channel Blockers; Cross-Sectional Studies; Drug Interactions; Female; Humans; Male; Rivaroxaban; Verapamil	2020
ASO Author Reflections: Amlodipine and Verapamil, Voltage-Gated Ca Annals of surgical oncology, 2021, Volume: 28, Issue:9 Topics: Amlodipine; Humans; Neoplasms; Neoplastic Stem Cells; Stomach; Verapamil	2021
Amlodipine and Verapamil, Voltage-Gated Ca Annals of surgical oncology, 2021, Volume: 28, Issue:9 Topics: Amlodipine; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Neoplastic Stem Cells; Stomach Neoplasms; Verapamil	2021
Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon. Medicina (Kaunas, Lithuania), 2023, May-25, Volume: 59, Issue:6 Topics: Amlodipine; Animals; Atorvastatin; Blood Pressure; Calcium; Calcium Channel Blockers; Calcium Channels; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Potassium Chloride; Rabbits; Rats; Rats, Wistar; Vasodilator Agents; Verapamil	2023
Pitavastatin and Lovastatin Exhibit Calcium Channel Blocking Activity Which Potentiate Vasorelaxant Effects of Amlodipine: A New Futuristic Dimension in Statin's Pleiotropy. Medicina (Kaunas, Lithuania), 2023, Oct-10, Volume: 59, Issue:10 Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Norepinephrine; Rabbits; Vasodilator Agents; Verapamil	2023